Reactive arthritis

Best Practice and Research: Clinical Rheumatology

Volumn 18, Issue 5 SPEC. ISS., 2004, Pages 689-703

  Toivanen, Auli ^a   Toivanen, Paavo ^b  

^a TURKU UNIVERSITY   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Ciprofloxacin; HLA B27; Inflammatory bowel disease; Reactive arthritis; Sacroiliitis

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CIPROFLOXACIN; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; GOLD SALT; HLA B27 ANTIGEN; IMMUNOLOGIC AGENT; LYMECYCLINE; METHOTREXATE; MYDRIATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISOLONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG MEGADOSE; ENTERITIS; ENTHESITIS; ERYTHEMA NODOSUM; ERYTHROCYTE SEDIMENTATION RATE; EYE INFLAMMATION; GASTROINTESTINAL SYMPTOM; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; IMMUNOPATHOGENESIS; INTESTINE INFECTION; KERATODERMA BLENNORRHAGICA; MICROBIOLOGICAL EXAMINATION; MUSCLE ATROPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OINTMENT; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PUSTULOSIS PALMOPLANTARIS; REACTIVE ARTHRITIS; REVIEW; RHEUMATIC DISEASE; RISK ASSESSMENT; SEROLOGY; SIDE EFFECT; UROGENITAL TRACT INFECTION;

EID: 9244247365     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2004.05.008     Document Type: Article

References (76)

1. Reiter H. Ueber eine bisher unerkannte Spirochäteninfektion (Spirochaetosis arthritica) Deutsche Medizinische Wochenschrift 42 1916 1535-1536
2. Ahvonen P. Sievers K. & Aho K. Arthritis associated with Yersinia enterocolitica infection Acta Rheumatologica Scandinavica 15 1969 232-253
3. Toivanen A. Reactive arthritis: Clinical features and treatment In: Hochberg M.C. Silman A.J. Smolen J.S. Weinblatt M.E. Weisman M.H. (Eds.) Rheumatology 2003 1233-1240 Mosby London
4. Toivanen A. & Toivanen P. Aetiopathogenesis of reactive arthritis Rheumatology in Europe 24 1995 5-8
5. Toivanen P. & Toivanen A. Two forms of reactive arthritis? Annals of the Rheumatic Diseases 58 1999 737-741
6. Keat A. Reactive arthritis or post-infective arthritis? Best Practice and Research Clinical Rheumatology 16 2002 507-522
7. De Vos M. Cuvelier C. Mielants H. et al. Ileocolonoscopy in seronegative spondyloarthropathy Gastroenterology 96 1989 339-344
8. Mielants H. Veys E.M. Cuvelier C. et al. Course of gut inflammation in spondylarthropathies and therapeutic consequences Baillière's Clinical Rheumatology 10 1996 147-164
9. Mielants H. De Vos M. & Veys E.M. Clinical aspects of enterogenic arthropathies Rheumatology in Europe 26 1997 6-10
10. Wollheim F.A. Enteropathic arthritis: How do the joints talk with the gut? Current Opinion in Rheumatology 13 2001 305-309
11. Toivanen A. Bacteria-triggered reactive arthritis: Implications for antibacterial treatment Drugs 61 2001 343-351
12. Gaston J.S.H. & Lillicrap M.S. Arthritis associated with enteric infection Best Practice and Research Clinical Rheumatology 17 2003 219-239
13. Granfors K. Jalkanen S. von Essen R. et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis The New England Journal of Medicine 320 1989 216-221
14. Merilahti-Palo R. Söderström K.-O. Lahesmaa-Rantala R. et al. Bacterial antigens in synovial biopsy specimens in Yersinia triggered reactive arthritis Annals of the Rheumatic Diseases 50 1991 87-90
15. Bas S. Griffais R. Kvien T. et al. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies Arthritis and Rheumatism 38 1995 1005-1013
16. Gérard H.C. Branigan P.J. Schumacher H.R. Jr et al. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression The Journal of Rheumatology 25 1998 734-742
17. Granfors K. Merilahti-Palo R. Luukkainen R. et al. Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis Arthritis and Rheumatism 41 1998 855-862
18. Kuipers J.G. Jürgens-Saathoff B. Bialowons A. et al. Detection of Chlamydia trachomatis in peripheral blood leukocytes of reactive arthritis patients by polymerase chain reaction Arthritis and Rheumatism 41 1998 1894-1895
19. Gerard H.C. Schumacher H.R. El-Gabalawy H. et al. Chlamydia pneumoniae present in the human synovium are viable and metabolically active Microbial Pathogenesis 29 2000 17-24
20. Schnarr S. Putschky N. Jendro M.C. et al. Chlamydia and Borrelia DNA in synovial fluid of patients with early undifferentiated oligoarthritis: Results of a prospective study Arthritis and Rheumatism 44 2001 2679-2685
21. Toivanen A. Granfors K. Lahesmaa-Rantala R. et al. Pathogenesis of Yersinia-triggered reactive arthritis: Immunological, microbiological and clinical aspects Immunological Reviews 86 1985 47-70
22. Toivanen P. & Toivanen A. Bacterial or reactive arthritis? Rheumatology in Europe 24 supplement 2 1995 253-255
23. Hermann E. Yu D.T.Y. Meyer zum Büschenfelde K.-H. et al. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis The Lancet 342 1993 646-650
24. Sieper J. Braun J. Wu P. et al. T cells are responsible for the enhanced synovial cellular immune response to triggering antigen in reactive arthritis Clinical and Experimental Immunology 91 1993 96-102
25. Salmi M. Rajala P. & Jalkanen S. Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion Journal of Clinical Investigation 99 1997 2165-2172
26. Salmi M. & Jalkanen S. Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules The Journal of Immunology 166 2001 4650-4657
27. May E. Marker-Hermann E. Wittig B.M. et al. Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy Gastroenterology 119 2000 1745-1755
28. Yin Z. Braun J. Neure L. et al. Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis Arthritis and Rheumatism 40 1997 1788-1797
29. Leirisalo M. Skylv G. Kousa M. et al. Followup study on patients with Reiter's diseases and reactive arthritis, with special reference to HLA-B27 Arthritis and Rheumatism 25 1982 249-259
30. Khan M.A. & Kellner H. Immunogenetics of spondyloarthropathies Rheumatic Disease Clinics of North America 18 1992 837-864
31. Al-Khonizy W. & Reveille J.D. The immunogenetics of the seronegative spondylarthropathies Baillière's Clinical Rheumatology 12 1998 567-588
32. Laivoranta S. Ilonen J. Tuokko J. et al. HLA frequencies in HLA-B27 negative patients with reactive arthritis Clinical and Experimental Rheumatology 13 1995 637-640
33. Saarinen M. Ekman P. Ikeda M. et al. Invasion of Salmonella into human intestinal epithelial cells is modulated by HLA-B27 Rheumatology 41 2002 651-657
34. Young J.L. Smith L. Matyszak M.K. et al. HLA-B27 expression does not modulate intracellular Chlamydia trachomatis infection of cell lines Infection and Immunity 69 2001 6670-6675
35. Bas S. Kvien T.K. Buchs N. et al. Lower level of synovial fluid interferon-gamma in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomatis reactive arthritis Rheumatology 42 2003 461-467
36. Braun J. Yin Z. Spiller I. et al. Low secretion of tumor necrosis factor alpha, but no other Th1 or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis Arthritis and Rheumatism 42 1999 2039-2044
37. Tertti R. & Toivanen P. Immune functions and inflammatory reactions in HLA-B27 positive subjects Annals of the Rheumatic Diseases 50 1991 731-734
38. Toivanen P. Koskimies S. Granfors K. et al. Bacterial antibodies in HLA-B27+ healthy individuals Arthritis and Rheumatism 36 1993 1633-1635
39. Kuon W. Holzhutter H.G. Appel H. et al. Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases The Journal of Immunology 167 2001 4738-4746
40. Märker-Hermann E. Meyer zum Büschenfelde K.-H. & Wildner G. HLA-B27-derived peptides as autoantigens for T lymphocytes in ankylosing spondylitis Arthritis and Rheumatism 40 1997 2047-2054
41. Wright V. Moll J.M.H. Reiter's disease In: Wright V. Moll J.M.H. (Eds.) Seronegative polyarthritis 1976 237-269 North Holland Amsterdam
42. Mielants H. & Veys E.M. The gut and reactive arthritis Rheumatology in Europe 24 1995 9-11
43. Kortekangas P. Aro H.T. Tuominen J. et al. Synovial fluid leukocytosis in bacterial arthritis vs. reactive arthritis and rheumatoid arthritis in the adult knee Scandinavian Journal of Rheumatology 21 1992 283-288
44. Sieper J. & Braun J. Problems and advances in the diagnosis of reactive arthritis The Journal of Rheumatology 26 1999 1222-1224
45. Sieper J. Braun J. & Kingsley G.H. Report on the Fourth International Workshop on Reactive Arthritis Arthritis and Rheumatism 43 2000 720-734
46. Braun J. Kingsley G. van der Heijde D. et al. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6, 1999 Journal of Rheumatology 27 2000 2185-2192
47. Toivanen A. & Toivanen P. Reactive arthritis Current Opinion in Rheumatology 12 2000 300-305
48. Sieper J. Rudwaleit M. Braun J. et al. Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays Arthritis and Rheumatism 46 2002 319-327
49. Kvien T.K. Glennås A. Melby K. et al. The natural history of reactive arthritis Rheumatology in Europe 24 1995 15-19
50. Yli-Kerttula T. Möttönen T. & Toivanen A. Different course of reactive arthritis in two HLA-B27 positive brothers with fatal outcome in one The Journal of Rheumatology 24 1997 2047-2050
51. Kalliomäki J.L. & Leino R. Follow-up studies of joint complications in yersiniosis Acta Medica Scandinavica 205 1979 521-525
52. Yli-Kerttula T. Tertti R. & Toivanen A. Ten-year follow up study of patients from a Yersinia pseudotuberculosis III outbreak Clinical and Experimental Rheumatology 13 1995 333-337
53. Konttinen Y.T. Nordström D.C. Bergroth V. et al. Occurrence of different ensuing triggering infections preceding reactive arthritis. A follow up study British Medical Journal 296 1988 1644-1645
54. Sairanen E. Paronen I. & Mähönen H. Reiter's syndrome: a follow-up study Acta Medica Scandinavica 185 1969 57-63
55. Mease P.J. Disease-modifying antirheumatic drug therapy for spondyloarthropathies: Advances in treatment Current Opinion in Rheumatology 15 2003 205-212
56. Creemers M.C. van Riel P.L. Franssen M.J. et al. Second-line treatment in seronegative spondylarthropathies Seminars in Arthritis and Rheumatism 24 1994 71-81
57. Toivanen A. Managing reactive arthritis Rheumatology 39 2000 117-119
58. Mielants H. & Veys E.M. HLA-B27 related arthritis and bowel inflammation. Part 1. Sulfasalazine (salazopyrin) in HLA-B27 related reactive arthritis Journal of Rheumatology 12 1985 287-293
59. Trnavsky K. Peliskova Z. & Vacha J. Sulphasalazine in the treatment of reactive arthritis Scandinavian Journal of Rheumatology supplement 67 1987 76-79
60. Clegg D.O. Reda D.J. Weisman M.H. et al. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs cooperative study Arthritis and Rheumatism 39 1996 2021-2027
61. Egsmose C. Hansen T.M. Andersen L.S. et al. Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial Annals of the Rheumatic Diseases 56 1997 32-36
62. Magid D. Schwartz B. Craft J. et al. Prevention of Lyme disease after tick bites. A cost-effectiveness analysis The New England Journal of Medicine 327 1992 534-541
63. Frydén A. Bengtsson A. Foberg U. et al. Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study British Medical Journal 301 1990 1299-1302
64. Locht H. Kihlström E. & Lindström F.D. Reactive arthritis after Salmonella among medical doctors-study of an outbreak The Journal of Rheumatology 20 1993 845-848
65. Bardin T. Enel C. Cornelis F. et al. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population Arthritis and Rheumatism 35 1992 190-194
66. Zhang Y. Gripenberg-Lerche C. Söderström K.-O. et al. Antibiotic prophylaxis and treatment of reactive arthritis. Lessons from an animal model Arthritis and Rheumatism 39 1996 1238-1243
67. Lauhio A. Leirisalo-Repo M. Lahdevirta J. et al. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis Arthritis and Rheumatism 34 1991 6-14
68. Lauhio A. Sorsa T. Lindy O. et al. The anticollagenolytic potential of lymecycline in the long-term treatment of reactive arthritis Arthritis and Rheumatism 35 1992 195-198
69. Beutler A.M. Hudson A.P. Whittum-Hudson J.A. et al. Chlamydia trachomatis can persist in joint tissue after antibiotic treatment in chronic Reiter's syndrome/reactive arthritis Journal of Clinical Rheumatology 3 1997 125-130
70. Wollenhaupt J. Hammer M. Pott H.G. et al. A double-blind placebo-controlled comparison of 2 weeks versus 4 months treatment with doxycycline in Chlamydia-induced arthritis Arthritis and Rheumatism 40 1997-S143
71. Toivanen A. Yli-Kerttula T. Luukkainen R. et al. Effect of antimicrobial treatment on chronic reactive arthritis Clinical and Experimental Rheumatology 11 1993 301-307
72. Sieper J. Fendler C. Laitko S. et al. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis Arthritis and Rheumatism 42 1999 1386-1396
73. Yli-Kerttula T. Luukkainen R. Yli-Kerttula U. et al. Effect of a three-month course of ciprofloxacin on the outcome of reactive arthritis Annals of the Rheumatic Diseases 59 2000 565-570
74. Wakefield D. McCluskey P. Verma M. et al. Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis Arthritis and Rheumatism 42 1999 1894-1897
75. Zhang Y. Toivanen A. & Toivanen P. Experimental Yersinia-triggered reactive arthritis; effect of a 3-week course with ciprofloxacin British Journal of Rheumatology 36 1997 541-546
76. Yli-Kerttula T. Luukkainen R. Yli-Kerttula U. et al. Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis Annals of the Rheumatic Diseases 62 2003 880-884